Frank T. Watkins, Director at Shockwave Medical, Inc. (SWAV), sold 14,950 shares at $209.33 ($3.0M) on 2023-01-09, disclosed to the SEC on 2023-01-10.
Open-market sale of $3.0M SWAV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $202.38 | 2,355 | $477K | 15.7% |
| 2 | $202.38 | 2,355 | $477K | 15.7% |
| 3 | $203.26 | 4,450 | $905K | 29.7% |
| 4 | $204.39 | 2,070 | $423K | 13.9% |
| 5 | $204.39 | 2,070 | $423K | 13.9% |
| 6 | $205.38 | 525 |
| $108K |
| 3.5% |
| 7 | $205.38 | 525 | $108K | 3.5% |
| 8 | $206.06 | 100 | $21K | 0.7% |
| 9 | $209.33 | 500 | $105K | 3.4% |
| Total | $203.67 avg | 14,950 | $3.0M | 100% |
| Filing → |
| SWAV | SELL | 2024-01-10 | $398K | — | Filing → |
| SWAV | SELL | 2023-11-21 | $926K | — | Filing → |
| SWAV | SELL | 2023-10-23 | $608K | — | Filing → |